{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:29Z","timestamp":1790259929433,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>ETS variant 4 (ETV4) has been implicated in the development of various cancers. However, the molecular events mediated by ETV4 in liver cancer are poorly understood, especially in hepatitis B virus (HBV)-associated liver hepatocellular carcinoma (LIHC). Here, we aimed to identify the target involved in ETV4-driven hepatocarcinogenesis. Bioinformatics analysis revealed that ETV4 was highly expressed in patients with HBV-associated LIHC, and HBV infection promoted the expression of ETV4 in LIHC cells. Inhibition of ETV4 repressed the proliferation, migration, invasion of LIHC cells and suppressed the secretion of HBV and the replication of HBV DNA. ANXA2 expression in LIHC patients was positively correlated with ETV4 expression. Chromatin immunoprecipitation and dual-luciferase reporter assays revealed that ETV4 elevated the ANXA2 expression at the transcriptional level by binding to the ANXA2 promoter. Overexpression of ANXA2 reversed the inhibitory effect of sh-ETV4 on the malignant biological behaviours of HBV-infected LIHC cells by activating the Wnt\/\u03b2-catenin pathway. In conclusion, ETV4 mediates the activation of Wnt\/\u03b2-catenin pathway through transcriptional activation of ANXA2 expression to promote HBV-associated LIHC progression.<\/jats:p>","DOI":"10.1093\/jb\/mvab088","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:13:04Z","timestamp":1627902784000},"page":"663-673","source":"Crossref","is-referenced-by-count":24,"title":["ETV4 mediates the Wnt\/\u03b2-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression"],"prefix":"10.1093","volume":"170","author":[{"given":"Tianfeng","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Liver Disease Infection, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou 215101, Jiangsu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, No. 39, Xiasha Tang, Mudu Town, Suzhou 215101, Jiangsu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2022021007410495900_mvab088-B1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"2022021007410495900_mvab088-B2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"2022021007410495900_mvab088-B3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/ijms22020479","article-title":"Risk factors and biomarkers for chronic hepatitis B associated hepatocellular carcinoma","volume":"22","author":"Pandyarajan","year":"2021","journal-title":"Int. J. Mol. Sci"},{"key":"2022021007410495900_mvab088-B4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jjco\/hyr016","article-title":"Surgical treatment for hepatocellular carcinoma","volume":"41","author":"Takayama","year":"2011","journal-title":"Jpn. J. Clin. Oncol"},{"key":"2022021007410495900_mvab088-B5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3109\/10409238.2013.838202","article-title":"Molecular mechanisms of ETS transcription factor-mediated tumorigenesis","volume":"48","author":"Kar","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol"},{"key":"2022021007410495900_mvab088-B6","first-page":"1","article-title":"ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors","volume":"1826","author":"Oh","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"2022021007410495900_mvab088-B7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1009576801226","article-title":"Role of Ets transcription factors in mammary gland development and oncogenesis","volume":"6","author":"Shepherd","year":"2001","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"2022021007410495900_mvab088-B8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2019.06.115","article-title":"ETV4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2","volume":"516","author":"Cheng","year":"2019","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2022021007410495900_mvab088-B9","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/hep.29738","article-title":"Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis","volume":"67","author":"Kim","year":"2018","journal-title":"Hepatology"},{"key":"2022021007410495900_mvab088-B10","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms14022652","article-title":"Annexin-phospholipid interactions. Functional implications","volume":"14","author":"Lizarbe","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"2022021007410495900_mvab088-B11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12032-014-0392-y","article-title":"Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis","volume":"32","author":"Liu","year":"2015","journal-title":"Med. Oncol"},{"key":"2022021007410495900_mvab088-B12","doi-asserted-by":"crossref","first-page":"101417","DOI":"10.1016\/j.mcp.2019.06.007","article-title":"Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating annexin A2 transcription","volume":"46","author":"Liu","year":"2019","journal-title":"Mol. Cell. Probes"},{"key":"2022021007410495900_mvab088-B13","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.7150\/thno.37892","article-title":"LncCCAT1 promotes breast cancer stem cell function through activating WNT\/beta-catenin signaling","volume":"9","author":"Tang","year":"2019","journal-title":"Theranostics"},{"key":"2022021007410495900_mvab088-B14","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-17-1915","article-title":"Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a","volume":"77","author":"Yan","year":"2017","journal-title":"Cancer Res"},{"key":"2022021007410495900_mvab088-B15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/ijms22010213","article-title":"Hepatitis B virus cure: targets and future therapies","volume":"22","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"2022021007410495900_mvab088-B16","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"D'Souza","year":"2020","journal-title":"World J. Gastroenterol"},{"key":"2022021007410495900_mvab088-B17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/bjc.2011.187","article-title":"PEA3\/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma","volume":"105","author":"Keld","year":"2011","journal-title":"Br. J. Cancer"},{"key":"2022021007410495900_mvab088-B18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2147\/OTT.S66692","article-title":"Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis","volume":"7","author":"Yuan","year":"2014","journal-title":"Oncotargets Ther"},{"key":"2022021007410495900_mvab088-B19","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1038\/oncsis.2012.20","article-title":"Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition","volume":"1","author":"Pellecchia","year":"2012","journal-title":"Oncogenesis"},{"key":"2022021007410495900_mvab088-B20","doi-asserted-by":"crossref","first-page":"109840","DOI":"10.1016\/j.biopha.2020.109840","article-title":"KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer","volume":"125","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother"},{"key":"2022021007410495900_mvab088-B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1541-7786.MCR-17-0219","article-title":"ETV4 facilitates cell-cycle progression in pancreatic cells through transcriptional regulation of cyclin D1","volume":"16","author":"Tyagi","year":"2018","journal-title":"Mol. Cancer Res"},{"key":"2022021007410495900_mvab088-B22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13058-018-0992-0","article-title":"ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis","volume":"20","author":"Dumortier","year":"2018","journal-title":"Breast Cancer Res"},{"key":"2022021007410495900_mvab088-B23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.23130","article-title":"ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally","volume":"59","author":"Wang","year":"2020","journal-title":"Mol. Carcinog"},{"key":"2022021007410495900_mvab088-B24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.canlet.2020.04.002","article-title":"ETV4 is a theragnostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner","volume":"482","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"key":"2022021007410495900_mvab088-B25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13045-020-00943-w","article-title":"ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21","volume":"13","author":"Cosi","year":"2020","journal-title":"J. Hematol. Oncol"},{"key":"2022021007410495900_mvab088-B26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.03.028","article-title":"PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway","volume":"452","author":"Yang","year":"2019","journal-title":"Cancer Lett"},{"key":"2022021007410495900_mvab088-B27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3748\/wjg.v26.i18.2126","article-title":"Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment","volume":"26","author":"Qiu","year":"2020","journal-title":"World J. Gastroenterol"},{"key":"2022021007410495900_mvab088-B28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2020.01.028","article-title":"Transgelin-2 contributes to proliferation and progression of hepatocellular carcinoma via regulating annexin A2","volume":"523","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2022021007410495900_mvab088-B29","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1136\/gutjnl-2019-319019","article-title":"S100A11\/ANXA2 belongs to a tumour suppressor\/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development","volume":"69","author":"Sobolewski","year":"2020","journal-title":"Gut"},{"key":"2022021007410495900_mvab088-B30","doi-asserted-by":"crossref","first-page":"152386","DOI":"10.1016\/j.prp.2019.03.015","article-title":"High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis","volume":"215","author":"Tang","year":"2019","journal-title":"Pathol. Res. Pract"},{"key":"2022021007410495900_mvab088-B31","first-page":"5","article-title":"Annexin A2 and cancer: a systematic review","volume":"52","author":"Christensen","year":"2018","journal-title":"Int. J. Oncol"},{"key":"2022021007410495900_mvab088-B32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1017\/S1431927619000679","article-title":"Annexin A2 enhances the progression of colorectal cancer and hepatocarcinoma via cytoskeleton structural rearrangements","volume":"25","author":"He","year":"2019","journal-title":"Microsc. Microanal"},{"key":"2022021007410495900_mvab088-B33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s13287-020-01928-9","article-title":"FOXQ1 promotes the osteogenic differentiation of bone mesenchymal stem cells via Wnt\/beta-catenin signaling by binding with ANXA2","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res. Ther"},{"key":"2022021007410495900_mvab088-B34","doi-asserted-by":"crossref","first-page":"114195","DOI":"10.18632\/oncotarget.23173","article-title":"ETV4 collaborates with Wnt\/beta-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor","volume":"8","author":"Zeng","year":"2017","journal-title":"Oncotarget"}],"container-title":["The Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jb\/advance-article-pdf\/doi\/10.1093\/jb\/mvab088\/39773129\/mvab088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/170\/5\/663\/42437794\/mvab088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/170\/5\/663\/42437794\/mvab088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:41:47Z","timestamp":1644478907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jb\/article\/170\/5\/663\/6339587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,8,4]]},"published-print":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jb\/mvab088","relation":{},"ISSN":["0021-924X","1756-2651"],"issn-type":[{"value":"0021-924X","type":"print"},{"value":"1756-2651","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,8,4]]}}}